glp-1 weight loss oral solution directions Decoding Medications Nutritional priorities to support GLP-1

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in popularity after the U.S

If more pharma companies move to DTC models, self-funded employers will likely need to adapt their benefits strategy to accommodate this shift

A 2026 review in the New England Journal of Medicine noted that questions about long-term dosing and durability of results remain open areas of research, not settled strategy

Load up that part of the plate first

Weight loss injections, primarily glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and tirzepatide (Zepbound), work through multiple mechanisms to promote weight reduction